Peripheral Intervention Market Size, Share, Trends, Growth Outlook

Peripheral Intervention Market is estimated to increase at a growth rate of 7.8% CAGR over the forecast period from 2024 to 2030.

The global Peripheral Intervention Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Device (Stents, Balloons, PTCA devices, Others), By Application (Vascular procedures, Oncology procedures, Neurology procedures, Skin procedures, Others).

An introduction to Peripheral Intervention Market in 2024

Providing minimally invasive treatment options for peripheral vascular diseases, the Peripheral Intervention Market offers a wide range of interventional procedures and devices for diagnosing and treating peripheral arterial and venous disorders, including peripheral artery disease (PAD), deep vein thrombosis (DVT), and peripheral vascular occlusions. Peripheral interventions include angioplasty, stenting, atherectomy, thrombectomy, and embolization procedures performed via catheter-based techniques, balloon dilation, or mechanical thrombectomy devices, restoring blood flow, relieving symptoms, and preventing complications in patients with peripheral vascular disorders. The market's growth is driven by technological innovations in endovascular devices, expanding indications for minimally invasive interventions, and the growing prevalence of peripheral vascular diseases associated with aging populations and comorbidities such as diabetes and obesity.

Peripheral Intervention market Trend: Shift Towards Minimally Invasive Procedures

A significant trend in the Peripheral Intervention market is the shift towards minimally invasive procedures. As advancements in medical technology continue to evolve, there's a growing preference among patients and healthcare providers for minimally invasive interventions over traditional open surgeries. Minimally invasive procedures offer several advantages, including reduced risk of complications, shorter hospital stays, faster recovery times, and improved patient outcomes. In the peripheral intervention market, this trend is evident in the increasing adoption of minimally invasive techniques such as angioplasty, stenting, atherectomy, and embolization for treating peripheral artery disease, venous insufficiency, and other vascular conditions. This shift towards minimally invasive interventions reflects a broader healthcare trend towards less invasive treatment approaches, driving growth and innovation in the peripheral intervention market.

Peripheral Intervention market Driver: Rising Incidence of Peripheral Vascular Diseases

The primary driver in the Peripheral Intervention market is the rising incidence of peripheral vascular diseases. Conditions such as peripheral artery disease (PAD), deep vein thrombosis (DVT), and varicose veins affect millions of individuals worldwide, posing significant health risks and impairing quality of life. Factors such as aging populations, sedentary lifestyles, obesity, diabetes, and smoking contribute to the increasing prevalence of peripheral vascular diseases. As the burden of these conditions continues to grow, there's a corresponding rise in demand for interventional procedures to diagnose and treat peripheral vascular diseases, driving market growth in the peripheral intervention segment. Healthcare providers are increasingly relying on peripheral interventions such as angioplasty, stenting, and thrombectomy to restore blood flow, alleviate symptoms, and prevent complications in patients with peripheral vascular diseases.

Peripheral Intervention market Opportunity: Expansion into Emerging Markets and Underserved Regions

One potential opportunity in the Peripheral Intervention market is the expansion into emerging markets and underserved regions. While developed markets such as North America and Europe dominate the peripheral intervention landscape, there's a growing need to address the unmet medical needs of patients in emerging markets and underserved regions with limited access to advanced healthcare services. By expanding into emerging markets in Asia, Latin America, and Africa, as well as rural and remote areas within developed countries, companies can tap into new patient populations, increase market penetration, and drive revenue growth in the peripheral intervention market. Moreover, investing in initiatives to enhance healthcare infrastructure, train healthcare professionals, and raise awareness about peripheral vascular diseases can further expand the Market Opportunity and improve patient outcomes in underserved regions.

Peripheral Intervention Market Market Segmentation

By Device
Stents
-Drug eluting stents
-Bio-absorbable stents
-Balloon inflation devices
-Bare metal stents
Balloons
-Normal balloons
-Drug eluting balloons
-Cutting balloons
-Scoring balloons
PTCA devices
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guidewires
-Percutaneous Transluminal Coronary Angioplasty (PTCA) balloons
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guiding catheters
Others
By Application
Vascular procedures
Oncology procedures
Neurology procedures
Skin procedures
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Peripheral Intervention Market Companies

Abbott Vascular
Angioscore Ltd
Bayer
Boston Scientific
Beckton, Dickinson and Company
Cook Medical
Cordis Corp
Covidien
Edward Lifesciences
Medtronic Inc
St. Jude Medical
Teleflex Medical
Terumo Interventional Systems Inc
Volcano Corp
W.L.Gore & Associates Ltd

Reasons to Buy the Peripheral Intervention Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Peripheral Intervention Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Peripheral Intervention Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Peripheral Intervention Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Peripheral Intervention Market Size Outlook, $ Million, 2021 to 2030
3.2 Peripheral Intervention Market Outlook by Type, $ Million, 2021 to 2030
3.3 Peripheral Intervention Market Outlook by Product, $ Million, 2021 to 2030
3.4 Peripheral Intervention Market Outlook by Application, $ Million, 2021 to 2030
3.5 Peripheral Intervention Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Peripheral Intervention Industry
4.2 Key Market Trends in Peripheral Intervention Industry
4.3 Potential Opportunities in Peripheral Intervention Industry
4.4 Key Challenges in Peripheral Intervention Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Peripheral Intervention Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Peripheral Intervention Market Outlook by Segments
7.1 Peripheral Intervention Market Outlook by Segments, $ Million, 2021- 2030
By Device
Stents
-Drug eluting stents
-Bio-absorbable stents
-Balloon inflation devices
-Bare metal stents
Balloons
-Normal balloons
-Drug eluting balloons
-Cutting balloons
-Scoring balloons
PTCA devices
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guidewires
-Percutaneous Transluminal Coronary Angioplasty (PTCA) balloons
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guiding catheters
Others
By Application
Vascular procedures
Oncology procedures
Neurology procedures
Skin procedures
Others

8 North America Peripheral Intervention Market Analysis and Outlook To 2030
8.1 Introduction to North America Peripheral Intervention Markets in 2024
8.2 North America Peripheral Intervention Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Peripheral Intervention Market size Outlook by Segments, 2021-2030
By Device
Stents
-Drug eluting stents
-Bio-absorbable stents
-Balloon inflation devices
-Bare metal stents
Balloons
-Normal balloons
-Drug eluting balloons
-Cutting balloons
-Scoring balloons
PTCA devices
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guidewires
-Percutaneous Transluminal Coronary Angioplasty (PTCA) balloons
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guiding catheters
Others
By Application
Vascular procedures
Oncology procedures
Neurology procedures
Skin procedures
Others

9 Europe Peripheral Intervention Market Analysis and Outlook To 2030
9.1 Introduction to Europe Peripheral Intervention Markets in 2024
9.2 Europe Peripheral Intervention Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Peripheral Intervention Market Size Outlook by Segments, 2021-2030
By Device
Stents
-Drug eluting stents
-Bio-absorbable stents
-Balloon inflation devices
-Bare metal stents
Balloons
-Normal balloons
-Drug eluting balloons
-Cutting balloons
-Scoring balloons
PTCA devices
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guidewires
-Percutaneous Transluminal Coronary Angioplasty (PTCA) balloons
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guiding catheters
Others
By Application
Vascular procedures
Oncology procedures
Neurology procedures
Skin procedures
Others

10 Asia Pacific Peripheral Intervention Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Peripheral Intervention Markets in 2024
10.2 Asia Pacific Peripheral Intervention Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Peripheral Intervention Market size Outlook by Segments, 2021-2030
By Device
Stents
-Drug eluting stents
-Bio-absorbable stents
-Balloon inflation devices
-Bare metal stents
Balloons
-Normal balloons
-Drug eluting balloons
-Cutting balloons
-Scoring balloons
PTCA devices
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guidewires
-Percutaneous Transluminal Coronary Angioplasty (PTCA) balloons
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guiding catheters
Others
By Application
Vascular procedures
Oncology procedures
Neurology procedures
Skin procedures
Others

11 South America Peripheral Intervention Market Analysis and Outlook To 2030
11.1 Introduction to South America Peripheral Intervention Markets in 2024
11.2 South America Peripheral Intervention Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Peripheral Intervention Market size Outlook by Segments, 2021-2030
By Device
Stents
-Drug eluting stents
-Bio-absorbable stents
-Balloon inflation devices
-Bare metal stents
Balloons
-Normal balloons
-Drug eluting balloons
-Cutting balloons
-Scoring balloons
PTCA devices
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guidewires
-Percutaneous Transluminal Coronary Angioplasty (PTCA) balloons
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guiding catheters
Others
By Application
Vascular procedures
Oncology procedures
Neurology procedures
Skin procedures
Others

12 Middle East and Africa Peripheral Intervention Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Peripheral Intervention Markets in 2024
12.2 Middle East and Africa Peripheral Intervention Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Peripheral Intervention Market size Outlook by Segments, 2021-2030
By Device
Stents
-Drug eluting stents
-Bio-absorbable stents
-Balloon inflation devices
-Bare metal stents
Balloons
-Normal balloons
-Drug eluting balloons
-Cutting balloons
-Scoring balloons
PTCA devices
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guidewires
-Percutaneous Transluminal Coronary Angioplasty (PTCA) balloons
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guiding catheters
Others
By Application
Vascular procedures
Oncology procedures
Neurology procedures
Skin procedures
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Vascular
Angioscore Ltd
Bayer
Boston Scientific
Beckton, Dickinson and Company
Cook Medical
Cordis Corp
Covidien
Edward Lifesciences
Medtronic Inc
St. Jude Medical
Teleflex Medical
Terumo Interventional Systems Inc
Volcano Corp
W.L.Gore & Associates Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Device
Stents
-Drug eluting stents
-Bio-absorbable stents
-Balloon inflation devices
-Bare metal stents
Balloons
-Normal balloons
-Drug eluting balloons
-Cutting balloons
-Scoring balloons
PTCA devices
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guidewires
-Percutaneous Transluminal Coronary Angioplasty (PTCA) balloons
-Percutaneous Transluminal Coronary Angioplasty (PTCA) guiding catheters
Others
By Application
Vascular procedures
Oncology procedures
Neurology procedures
Skin procedures
Others